Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Nicotine Patch and Bupropion for Smoking Cessation in Younger, Low-Income, and Minority Individuals
NCT00308763Phase 4Completed
- Sponsor
- University of Tennessee
- Start
- Jan 2004
- Primary completion
- Dec 2008
- Modality
- Transdermal Patches, Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of nicotine patch, bupropion in Tobacco Use Disorder (TUD), sponsored by University of Tennessee. Started Jan 2004; status: completed.
02
Drugs
nicotine patchbupropion
03
Conditions
Tobacco Use Disorder (TUD)
Beyond the preview
Go deeper on NCT00308763.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00308763.